Clinical Trial Update: Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing daily single-dose triple therapy to conventional triple therapy for Helicobacter pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Zahra Vahdat Shariatpanahi | Conditions: Helicobacter Infection | Phase 4 | Status: COMPLETED